Flagship Pioneering Appoints Stephen Hahn as Chief Medical Officer, Effective June 16, 2021

Flagship Pioneering announced that Stephen Hahn, M.D. will help lead its Preemptive Medicine and Health Security initiative as Chief Medical Officer, effective June 16, 2021. Dr. Hahn served as the U.S. Food and Drug Administration Commissioner from 2019–2021. Prior to joining the FDA, he was the Chief Medical Executive, The University of Texas MD Anderson Cancer Center.

Flagship Pioneering, formerly known as Flagship Ventures is a private equity and venture capital firm specializing in incubation, seed stage, early, later and growth stage investments. It was founded in 2000 and is based in Cambridge, Massachusetts with additional offices in Cambridge, Massachusetts and Ann Arbor, Michigan.